Mediware Chief Operating Officer to Step Down Later This Year

Mediware Chief Operating Officer to Step Down Later This Year

John Damgaard Resigns From the Lenexa-Based Software Company

LENEXA, Kan., June 1, 2012 (GLOBE NEWSWIRE) -- Mediware Information Systems,
Inc. (Nasdaq:MEDW) announced that John Damgaard will step down as chief
operating officer of the company effective September 7, 2012. Mr. Damgaard
leaves Mediware to join a private company as its president.

"It is with sadness, but also pride, that I announce the departure of John
Damgaard," said Thomas Mann, Mediware's president and chief executive officer.
"He has been a tremendous asset in positioning the Company for continued
success. While we will all miss him, he is taking the next step in his career
and we wish him much continued success."

"I have spent almost nine years working to grow the business and establish
Mediware software as the leading edge in the segments of care we serve," said
Mr. Damgaard."I am very proud of all that we have accomplished during my time
at Mediware and look forward to watching the company from the sidelines as it
continues to grow."

Mr. Damgaard will continue in his current role throughout the summer to ensure
a smooth transition.Mr. Mann will leverage the time to consider several
options, including hiring a new Chief Operating Officer or restructuring roles
within the company to take advantage of the strong leaders that Mediware has
developed over the years.

About Mediware

Mediware delivers interoperable best-of-breed software systems that improve
efficiencies and address safety concerns, enabling healthcare organizations to
improve care processes while decreasing costs. Core Mediware solutions include
blood management technologies for hospitals and blood centers; cell therapy
solutions for cord blood banks, cancer treatment centers and research
facilities; medication management solutions for hospitals, behavioral health
facilities, infusion and specialty pharmacy providers; and business
intelligence-based performance management solutions for clinical, regulatory
and financial aspects of the broader healthcare market. For more information
about Mediware products and services, visit our website at

The Mediware Information Systems, Inc. logo is available at

Certain statements in this press release may constitute "forward-looking"
statements within the meaning of the Private Securities Litigation Reform Act
of 1995, as the same may be amended from time to time (the "Act") andare
intended to be covered by the safe harbor created thereby. Such
forward-looking statements are not necessarily based on historical facts and
involve known and unknown risks, uncertainties and other factors which may
cause the actual results of the Company to be materially different from any
future results expressed or implied by such forward looking statements. These
risk and uncertainties include but are not limited to those disclosed in the
Company's Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and
Current Reports on Form 8-K. The Company does not intend to, and undertakes no
obligation to, update forward-looking statements to reflect changed
assumptions, the occurrence of unanticipated events or changes in future
operating results, financial condition or business over time. The Company
regularly posts important information to the investor relations section of its

CONTACT: John Van Blaricum

MEDIWARE Information Systems, Inc. Logo
Press spacebar to pause and continue. Press esc to stop.